Department of Psychiatry, University of Bonn
Bonn, North Rhine-Westphalia, 53105, Germany
NCT Number: NCT01701180
Mounting evidence indicates that the intranasal administration of the neuropeptide oxytocin has prosocial effects. However, the neural substrates of these effects are still unclear. The investigators hypothesized that a single dose administration of oxytocin should increase empathogenic and affiliative responses and that these effects are mediated by an increased insula activity.
Looking for future studies?
Notify Me18 year–60 year
Male
Interventional
Early Phase 1
Bonn, North Rhine-Westphalia, 53105, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
24 IU; 3 puffs per nostril, each with 4 IU OXT
Other names: Oxytocin: Syntocinon-Spray, Novartis
Time frame: About one hour after the intranasal administration of oxytocin
All subjects are scanned while they view emotional and neutral faces and rate their empathy for these stimuli.
Time frame: About one hour after the intranasal administration of oxytocin
All subjects are scanned while they view a picture of their mate and and an unknown female.
University Hospital, Bonn
Other
Neural Correlates of the Empathogenic and Affiliative Actions of Oxytocin
Acronym: ODIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details